EPISODE · Mar 3, 2026 · 8 MIN
Spine - Stereotactic Radiotherapy for Spinal Metastases: Outcomes and Prognostic Factors
from Neurosurgery Hub Podcast · host Neurosurgery Hub Team
This episode delves into the clinical outcomes and prognostic factors associated with stereotactic radiotherapy for spinal metastases in patients with epidural spinal cord compression grades 1-2. Based on the full text of a study published in Cancer Medicine in 2026, we review a retrospective analysis that examined treatment efficacy and patient characteristics influencing outcomes. Key findings include insights into pain relief, neurological improvement, and survival rates, offering valuable information for oncologists and radiation oncologists managing these complex cases. This discussion aims to enhance treatment planning and patient selection for stereotactic radiotherapy in this specific patient population. Please note this podcast is for informational purposes and not a substitute for professional medical advice.
What this episode covers
This episode delves into the clinical outcomes and prognostic factors associated with stereotactic radiotherapy for spinal metastases in patients with epidural spinal cord compression grades 1-2. Based on the full text of a study published in Cancer Medicine in 2026, we review a retrospective analysis that examined treatment efficacy and patient characteristics influencing outcomes. Key findings include insights into pain relief, neurological improvement, and survival rates, offering valuable information for oncologists and radiation oncologists managing these complex cases. This discussion aims to enhance treatment planning and patient selection for stereotactic radiotherapy in this specific patient population. Please note this podcast is for informational purposes and not a substitute for professional medical advice.
NOW PLAYING
Spine - Stereotactic Radiotherapy for Spinal Metastases: Outcomes and Prognostic Factors
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m